Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(e))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Name:	us-gaap_LicensesRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

License and Collaboration Agreements (Details) - USD ($)	1 Months Ended				12 Months Ended
	Jan. 31, 2017	Jan. 31, 2016	Jan. 31, 2015	Jan. 31, 2013	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Guarantor Obligations [Line Items]
License fee and other revenues					$ 284,290	$ 386,941	$ 1,250,000
The Bayer Group (formerly Algeta ASA) [Member]
Guarantor Obligations [Line Items]
Upfront cash payment and other payments received under collaboration agreement				$ 6,000,000
License fee and other revenues	$ 300,000	$ 300,000	$ 300,000				$ 1,000,000